Industry Partners

The SVS VQI works closely with industry using real-world registry data to advance the understanding of devices and therapies, improve patient safety, and streamline development.

Retrospective and Prospective Projects: Manufacturers can use the SVS VQI for retrospective or prospective projects to evaluate devices and therapies, working with the SVS PSO, FDA and M2S:

• Take advantage of the existing network of over 750 SVS VQI centers participating in SVS VQI
• Reduce costs by simplifying site contracting, avoiding IRB fees
• Create dynamic content on the M2S PATHWAYS web-based platform
• Supplement existing data with required elements to greatly speed project completion and meet regulatory requirements
• Provided necessary comparative device data as opposed to prospectively collecting this data over an estimated three years

Please see the latest documents describing industry projects:

• WEBINAR: Leveraging Real World Evidence Using the Vascular Quality Initiative
• 2021 SVS VQI Annual Report
• 2020 SVS VQI Annual Report
• Data Sharing Proposal Form
• Industry Overview
• SVS VQI Post-Approval Surveillance Process